More on Adjuvant Therapy in Resected Melanoma

被引：3
|
作者：
Faries, Mark B. [1 ]
Stern, Stacey [2 ]
Thompson, John F. [3 ]
机构：
[1] Angeles Clin & Res Inst, Los Angeles, CA 90025 USA
[2] John Wayne Canc Inst, Santa Monica, CA USA
[3] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 17期
关键词：
SENTINEL-NODE BIOPSY;
D O I：
10.1056/NEJMc1803342
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1656 / 1657
页数：2
相关论文
共 50 条
  • [41] Adjuvant therapy of resected gastric cancer is necessary
    Carrato, A
    Gallego-Plazas, J
    Guillen-Ponce, C
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S105 - S108
  • [42] Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
    Eggermont, Alexander M. M.
    Blank, Christian U.
    Mandala, Mario
    Long, Georgina, V
    Atkinson, Victoria
    Dalle, Stephane
    Haydon, Andrew
    Lichinitser, Mikhail
    Khattak, Adnan
    Carlino, Matteo S.
    Sandhu, Shahneen
    Larkin, James
    Puig, Susana
    Ascierto, Paolo A.
    Rutkowski, Piotr
    Schadendorf, Dirk
    Koornstra, Rutger
    Hernandez-Aya, Leonel
    Maio, Michele
    van den Eertwegh, Alfonsus J. M.
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Jamal, Rahima
    Lorigan, Paul
    Ibrahim, Nageatte
    Marreaud, Sandrine
    van Akkooi, Alexander C. J.
    Suciu, Stefan
    Robert, Caroline
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19): : 1789 - 1801
  • [43] The case for adjuvant BRAF-targeted therapy versus adjuvant anti-PD-1 therapy for patients with resected, high-risk melanoma
    Mooradian, Meghan J. J.
    Sullivan, Ryan J. J.
    CANCER, 2023, 129 (14) : 2117 - 2121
  • [44] SALVO: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma.
    Kottschade, Lisa A.
    Pond, Gregory Russell
    Olszanski, Anthony J.
    Zakharia, Yousef
    Domingo-Musibay, Evidio
    Hauke, Ralph J.
    Curti, Brendan D.
    Schober, Sarah
    Milhem, Mohammed M.
    Block, Matthew Stephen
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Adjuvant nivolumab plus ipilimumab for resected stage IV melanoma
    Sullivan, Ryan Joseph
    LANCET, 2020, 395 (10236): : 1524 - 1525
  • [46] Adjuvant therapy for surgically resected pancreatic adenocarcinoma
    Abbruzzese, James L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (09): : 1066 - 1067
  • [47] Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
    Fenocchio, Elisabetta
    Filippi, Roberto
    Lombardi, Pasquale
    Quara, Virginia
    Milanesio, Michela
    Aimar, Giacomo
    Leone, Francesco
    Aglietta, Massimo
    CANCERS, 2019, 11 (10)
  • [48] THE USE OF NIVOLUMAB ADJUVANT THERAPY IN A 5-YEAR-OLD WITH STAGE IIIC RESECTED SPITZOID MELANOMA
    Mastropolo, Rosemarie
    Kirkwood, John
    Seynnaeve, Brittani
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S166 - S166
  • [49] Assessing the value of nivolumab (NIVO) versus placebo (PBO) and ipilimumab (IPI) as adjuvant therapy for resected melanoma
    Freeman, Morganna Louise
    Shoushtari, Alexander Noor
    Betts, Keith A.
    Gupte-Singh, Komal
    Du, Ella X.
    Ritchings, Corey
    Rao, Sumati
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Results of adjuvant therapy in resected pancreatic cancer
    Åke Andrén-Sandberg
    Pia Lena Bäckman
    Roland Andersson
    International journal of pancreatology, 1997, 21 (1) : 31 - 38
12345